...Well, good morning, everybody. Welcome to the Imugene azer-cel webinar, in which we're looking forward to updating you on this incredibly exciting data that we released recently. The program for today is, we'll take you through a slide presentation on the data, and then at the end of that, we will be open for questions from all of you. We've received a great many so far, and the plan is to answer those. But as further questions arise, please submit them and we'll endeavor to get all the way through them. So at this point, I'd like to hand over to Leslie and she will take it from there. Leslie? Leslie Chong ...